Anne Dropmann

Heidelberg University — Germany

Medicine · Health Sciences

8h-index264citations56works1.22yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver physiology and pathology(27), TGF-β signaling in diseases(15), Liver Disease Diagnosis and Treatment(12), Pediatric Hepatobiliary Diseases and Treatments(11), Pancreatic and Hepatic Oncology Research(6)

Publications56 total

Transforming Growth Factor-β1 Induces Loss of Hepatic Zonation and Endothelial-to-Fibrotic Transition in Vivo
Zeitschrift für Gastroenterologie·2026
Immunoglobulin G binding as a quantitative marker of hepatocellular death across acute and chronic liver injury
Zeitschrift für Gastroenterologie·2026
Immunoglobulin G binding as a quantitative marker of hepatocellular death across acute and chronic liver injury
2025
Detailing the immune response to TGFB2 in cholestatic liver disease of PSC patients and MDR2KO mice
Zeitschrift für Gastroenterologie·2025
Preclinical evaluation of human ABCB5+ skin-derived stem cells reveals regenerative mechanisms and prognostic markers in a novel ACLF mouse model
Zeitschrift für Gastroenterologie·2025
ECM1 as a biomarker for liver disease: Development of an ELISA and analysis of human serum levels
Zeitschrift für Gastroenterologie·2025
THU-048 Cell-type specific roles of TGF-β2 signaling in cholestatic liver disease progression and therapeutic targeting
Journal of Hepatology·2025
CD271 sorting for improved liver cell isolation: Semiautomated and simultaneous preparation of parenchymal and non-parenchymal cells from mouse and human livers
2025Open Access
Linker Phosphorylation of Smad3 as a Driver of Cholangiocarcinoma Progression and Chemotherapy Resistance
Zeitschrift für Gastroenterologie·2025
Cellular cytokinesis, hyperplasia and hypertrophy define critical phases for liver regeneration efficiency
Zeitschrift für Gastroenterologie·2025
Cell type specific decoding of TGF-β2 production, signaling and outcome in the dynamics of cholestatic liver disease
Zeitschrift für Gastroenterologie·2025
Effects of TGF-β2 on cholangiocyte activation and the canonical TGF-β signaling pathway
Zeitschrift für Gastroenterologie·2024
Direct Ingestion of Oxidized Red Blood Cells (Efferocytosis) by Hepatocytes
Hepatic Medicine Evidence and Research·2024· 3 citedOpen Access
Das Tumorgefäß-Targeting iRGD-Peptid verbessert durch einen induzierten Tumor-Blut-Transport die diagnostische Genauigkeit von Tumormarkern
Zeitschrift für Gastroenterologie·2024
Mechanisms underpinning the effect of exercise on the non-alcoholic fatty liver disease: review
PubMed·2024· 6 citedOpen Access
The TGF-β1 target WISP1 is highly expressed in liver cirrhosis and cirrhotic HCC microenvironment and involved in pro- and anti-tumorigenic effects
Biochemical and Biophysical Research Communications·2024· 5 citedOpen Access
Dynamic YAP expression in the non-parenchymal liver cell compartment controls heterologous cell communication
Cellular and Molecular Life Sciences·2024· 8 citedOpen Access
Tumour-specific activation of a tumour-blood transport that may improve the diagnostic accuracy of blood tumour markers
Zeitschrift für Gastroenterologie·2024
Reciprocal Inhibitory Regulation of TGF-β1 Signaling and Cholesterol Metabolism in Hepatocytes
Zeitschrift für Gastroenterologie·2024
The Interplay of TGF-β1 and Cholesterol Orchestrating Hepatocyte Cell Fate, EMT, and Signals for HSC Activation
Cellular and Molecular Gastroenterology and Hepatology·2023· 16 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Steven Dooley(34), Seddik Hammad(14), NM Meindl-Beinker(13), Albrecht Piiper(9), Andreas Teufel(9), Hanna Korhonen(8), Bedair Dewidar(8), Matthias Ebert(8), T. Dediulia(7), Seddik Hammad(6), Timo Itzel(6), Matthias P. Ebert(6), Michel Janicot(5), Thomas S. Weiß(5), Nadja M. Meindl‐Beinker(4), Timo Gaiser(4), Claudia Rubie(4), Tao Lin(4), Oliver Waidmann(4), Nuh N. Rahbari(4)